Segments - Automated Breast Ultrasound Systems Market by Product (Automated Breast Volume Scanner and Automated Breast Ultrasound System), End-user (Diagnostic Imaging Centers, Specialty Centers, Hospitals, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
The global automated breast ultrasound systems market size was USD 1.72 Billion in 2023 and is projected to reach USD 3.96 Billion by 2032, expanding at a CAGR of 9.7% during 2024–2032. The market growth is attributed to the growing emphasis on early disease detection and diagnosis.
Increasing demand for advanced diagnostic technologies led to the growing demand for automated breast ultrasound systems (ABUSs), thereby boosting the market. ABUS finds expanding utility across various sectors, including diagnostics imaging centers, hospitals, and specialty clinics. These provide three-dimensional images of breast tissue for diagnostics purposes to detect abnormalities with high precision and efficiency for clinicians. Moreover, the growing population of women suffering from breast cancer further boosts the market.
The use of artificial intelligence is likely to boost the automated breast ultrasound systems market. AI technologies are enhancing the interpretation of imaging data to facilitate early detection and improving treatment planning for breast cancer. Moreover, AI-driven predictive analytics and risk stratification models enable personalized patient care, guiding clinicians in tailoring treatment strategies based on individualized disease profiles and prognostic factors.
Increasing awareness regarding the importance of early breast cancer detection is anticipated to drive the market during the forecast period. Initiatives from healthcare organizations and governments across the globe to promote breast cancer screening programs help to raise awareness among women. Additionally, the growing prevalence of breast cancer cases globally necessitates the need for advanced diagnostic tools, including ABUS, to enhance early detection rates, which further boosts the market.
High cost associated with automated breast ultrasound systems (ABUS) is expected to hamper the market in the coming years. The initial investment required for purchasing ABUS equipment as well as recurring costs associated with maintenance, training, and software updates reduce their widespread adoption in various healthcare facilities and diagnostic centers. Furthermore, the limited availability of skilled healthcare professionals to operate advanced automated breast ultrasound systems further hinders the market during the forecast period.
Rising investments in research and development activities are anticipated to create immense opportunities for the players competing in the market during the forecast period. Manufacturers are focusing on improving image quality, enhancing system ergonomics, and integrating advanced software solutions for image analysis and interpretation. Furthermore, the integration of multi-parametric imaging protocols and functional imaging biomarkers into ABUS platforms enhances diagnostic accuracy further propelling the market.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes | Details |
Report Title | Automated Breast Ultrasound Systems Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2023 |
Historic Data | 2017 -2022 |
Forecast Period | 2024–2032 |
Segmentation | Product (Automated Breast Volume Scanner and Automated Breast Ultrasound System) and End-user (Diagnostic Imaging Centers, Specialty Centers, Hospitals, and Others) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report | Canon Medical Systems, USA; CapeRay; Delphinus Medical Technologies, Inc; General Electric; Hitachi, Ltd; Koninklijke Philips N.V; MetriTrack, Inc; Nova Medical; Olympus Corporation; QView Medical; Real Imaging & Research center; Seno Medical; Siemens Healthcare Private Limited; SIUI; SonoCiné; Supersonic Imagine; Theraclion; and Volpara Health Limited |
Based on product, the automated breast ultrasound systems market is divided into automated breast volume scanner and automated breast ultrasound system. The automated breast ultrasound system (ABUS) segment held the major share of the market in 2023, as they offer enhanced imaging capabilities and improved diagnostic accuracy as compared to traditional ultrasound methods, making them preferred tools for breast cancer screening and detection.
The automated breast volume scanner (ABVS) segment is expected to expand at a significant growth rate in the coming years, due to the growing demand for personalized medicine and targeted breast cancer therapies. These factors underscore the importance of comprehensive imaging modalities, including ABVS in facilitating precise diagnosis and treatment planning. Furthermore, the expanding market presence of ABVS manufacturers and strategic partnerships with healthcare organizations are boosting the segment.
On end user the basis of , the global market is segregated into diagnostic imaging centers, specialty centers, hospitals, and others. The hospitals segment is anticipated to expand at a substantial CAGR during the forecast period, due to the availability of specialized breast imaging departments and skilled healthcare professionals in these types of medical facilities. Hospitals adopt automated breast ultrasound systems for breast cancer screening and diagnosis. Moreover, hospitals often attract a high patient pool for advanced diagnostics, which further contributes to the high demand for automated breast ultrasound systems in hospital settings.
In terms of region, the global automated breast ultrasound systems market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America held a major market share in 2023, due to the presence of advanced healthcare infrastructure and robust research & development activities, facilitating the widespread adoption of innovative medical technologies, including automated breast ultrasound systems. Moreover, the high prevalence of breast cancer cases further boosts the market in this region.
The market in Asia Pacific is projected to expand at a significant pace in the coming years, owing to the growing aging population as well as increase in breast cancer incidence and diagnostic needs.
According to a report published by the United States Census Bureau on June 21, 2022, there are 414 million Asia-based people aged 65 and above. This number is approximately 20% higher than the total US population in 2020. Furthermore, the report states that by the year 2060, 33.7% of Eastern Asia's population is estimated to be aged 65 and above.
The automated breast ultrasound systems market has been segmented on the basis of
Region
Key players competing in the global automated breast ultrasound systems market are Canon Medical Systems, USA; CapeRay; Delphinus Medical Technologies, Inc; General Electric; Hitachi, Ltd; Koninklijke Philips N.V; MetriTrack, Inc; Nova Medical; Olympus Corporation; QView Medical; Real Imaging & Research center; Seno Medical; Siemens Healthcare Private Limited; SIUI; SonoCiné; Supersonic Imagine; Theraclion; and Volpara Health Limited
These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base globally.
On November 17, 2023, SAMSUNGHEALTHCARE, a healthcare technology provider, recently unveiled new ultrasound system, the V6. This system is specially designed to cater to the needs of women's health. It offers comprehensive imaging capabilities in 2D, 3D, and color image quality. The V6 has received clearance from the US Food and Drug Administration for the commercial use. It is budget-friendly and designed to meet the workflow and productivity requirements of healthcare providers.